secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001493152-22-032503
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace stockholders approve equity plan share increases and reverse split authorization
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2019 Equity Incentive Plan, increasing authorized shares by 1,000,000 to total 2,230,000.
- Stockholders approved amendment to Employee Stock Purchase Plan, increasing authorized shares by 1,000,000 to total 2,000,000.
- Stockholders granted board discretionary authority to effect a reverse stock split within range of 1-for-2 to 1-for-10, within one year.
- Stephen J. Sullivan elected as Class I director, receiving 8,793,313 votes for and 820,085 withhold.
- Ratification of EisnerAmper LLP as independent auditor for fiscal year ending Dec 31, 2022 approved with 11,041,434 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315222032503/0001493152-22-032503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315222032503/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-032503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer